Bleichroeder LP’s Genelux GNLX Stock Holding History

Bleichroeder LP’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.16M	Hold	1,380,666	–	–	0.74%	21
2026 Q1	$3.34M	Buy	1,380,666 +666,666	+93%	+$1.82M	0.58%	24
2025 Q4	$3.11M	Hold	714,000	–	–	0.55%	22
2025 Q3	$3M	Hold	714,000	–	–	0.58%	22
2025 Q2	$2.05M	Hold	714,000	–	–	0.5%	23
2025 Q1	$1.93M	Buy	+714,000	New	+$2.68M	0.51%	19

Other funds holding GNLX

WDC

Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bleichroeder LP's GNLX Position: Q2 2026 in Review

Bleichroeder LP held its Genelux (GNLX) position steady in Q2 2026 at 1,380,666 shares worth $4.16M. The position accounts for 0.74% of the portfolio, ranked #21.

Bleichroeder LP first reported a position in GNLX in Q1 2025 and has held it in 6 quarters since. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

Bleichroeder LP held 1,380,666 shares of Genelux worth $4.16M as of Q2 2026.
Bleichroeder LP left its Genelux share count unchanged in Q2 2026.
Genelux made up 0.74% of Bleichroeder LP's portfolio in Q2 2026, its #21 holding.
Bleichroeder LP first reported a position in Genelux in Q1 2025 and has held it in 6 quarters since.
72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.